Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
about
Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis.M7824, a novel bifunctional anti-PD-L1/TGFβ Trap fusion protein, promotes anti-tumor efficacy as monotherapy and in combination with vaccine.CNS cancer immunity cycle and strategies to target this for glioblastoma.Epigenetic priming of both tumor and NK cells augments antibody-dependent cellular cytotoxicity elicited by the anti-PD-L1 antibody avelumab against multiple carcinoma cell types
P2860
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
@en
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein
@nl
type
label
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
@en
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein
@nl
prefLabel
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
@en
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein
@nl
P2093
P2860
P356
P1433
P1476
Analyses of functions of an anti-PD-L1/TGFβR2 bispecific fusion protein (M7824).
@en
P2093
Caroline Jochems
Hing C Wong
James L Gulley
Jeffrey Schlom
Patrick Soon-Shiong
Samuel Troy Pellom
Sarah R Tritsch
P2860
P304
75217-75231
P356
10.18632/ONCOTARGET.20680
P407
P577
2017-09-08T00:00:00Z